• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角膜和结膜上皮内瘤变的晚期复发及长期随访的必要性

Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia.

作者信息

Tabin G, Levin S, Snibson G, Loughnan M, Taylor H

机构信息

Department of Ophthalmology, University of Melbourne, Royal Victorian Eye and Ear Hospital, Victoria, Australia.

出版信息

Ophthalmology. 1997 Mar;104(3):485-92. doi: 10.1016/s0161-6420(97)30287-5.

DOI:10.1016/s0161-6420(97)30287-5
PMID:9082277
Abstract

PURPOSE

The purpose of the study was to elucidate the natural history of corneal-conjunctival intraepithelial neoplasia (CIN) and suggest treatment and follow-up guidelines.

METHODS

The records of all histologically proven cases of CIN at the Royal Victorian Eye and Ear Hospital between 1979 and 1994 were reviewed.

RESULTS

Seventy-nine eyes of 76 patients had a pathologic diagnosis of CIN and were observed for up to 15 years. The lesion recurred in 31 eyes (39%) overall. There was no statistical difference shown in the likelihood of recurrence based on histologic classification. Complete excision was attempted in each case. In 18 eyes, dysplastic cells were evident at the excision margin. Ten (56%) of these tumors recurred, compared to a 33% recurrence rate in completely excised lesions. The time to the first recurrence ranged from 33.0 days to 11.5 years between the first and second surgeries, with 11 lesions recurring after more than 4 years. Incompletely excised lesions reappeared more rapidly (average, 2.5 years) than did those with clear surgical margins (average, 3.8 years). Seven cases progressed to invasive squamous cell carcinoma and four cases led to blindness or removal of the eye.

CONCLUSIONS

This study suggests that excision margin at the time of surgery is the most important factor in predicting recurrence. The slow growth of the recurrent lesions combined with the ever-present malignant potential leads the authors to suggest that all patients with a history of CIN warrant annual follow-up for the remainder of their lives.

摘要

目的

本研究旨在阐明角膜结膜上皮内瘤变(CIN)的自然病程,并提出治疗及随访指南。

方法

回顾了1979年至1994年间皇家维多利亚眼耳医院所有经组织学证实的CIN病例记录。

结果

76例患者的79只眼经病理诊断为CIN,并进行了长达15年的观察。总体上,31只眼(39%)出现病变复发。基于组织学分类,复发可能性无统计学差异。每例均尝试完整切除。18只眼中,切除边缘可见发育异常细胞。其中10只眼(56%)复发,而完整切除病变的复发率为33%。首次手术与第二次手术之间首次复发时间为33.0天至11.5年,11个病变在4年多后复发。切除不完全的病变比手术切缘清晰者复发更快(平均2.5年 vs. 平均3.8年)。7例进展为浸润性鳞状细胞癌,4例导致失明或眼球摘除。

结论

本研究表明,手术时的切除边缘是预测复发的最重要因素。复发病变生长缓慢且始终存在恶变潜能,因此作者建议所有有CIN病史的患者在余生都需每年进行随访。

相似文献

1
Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia.角膜和结膜上皮内瘤变的晚期复发及长期随访的必要性
Ophthalmology. 1997 Mar;104(3):485-92. doi: 10.1016/s0161-6420(97)30287-5.
2
Immunosuppression and HIV in young patients with ocular surface dysplasia.
Ophthalmology. 1997 Oct;104(10):1531. doi: 10.1016/s0161-6420(97)30101-8.
3
Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.亚洲人群眼表鳞状细胞肿瘤的临床和病理特征。
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2569-73. doi: 10.1007/s00417-013-2450-0. Epub 2013 Sep 5.
4
Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.局部应用干扰素α-2b治疗复发性角膜和结膜上皮内瘤变
Ophthalmology. 2004 Sep;111(9):1755-61. doi: 10.1016/j.ophtha.2004.01.034.
5
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.角膜和结膜上皮内及浸润性肿瘤的处理:长期随访。
Cornea. 2009 Oct;28(9):986-8. doi: 10.1097/ICO.0b013e3181a0a23d.
6
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.切除手术后眼表鳞状上皮瘤复发的预测因素。
Ophthalmology. 2012 Oct;119(10):1974-81. doi: 10.1016/j.ophtha.2012.04.022. Epub 2012 Jun 14.
7
Conjunctival and corneal intraepithelial and invasive neoplasia.
Ophthalmology. 1986 Feb;93(2):176-83. doi: 10.1016/s0161-6420(86)33764-3.
8
Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.结膜和角膜鳞状细胞癌及上皮内瘤变:101 例分析。
Ophthalmology. 2012 Feb;119(2):233-40. doi: 10.1016/j.ophtha.2011.08.005. Epub 2011 Dec 20.
9
The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.手术广泛切除联合羊膜移植并辅助局部应用丝裂霉素C治疗复发性结膜-角膜上皮内瘤的效果
Semin Ophthalmol. 2014 Jul;29(4):192-5. doi: 10.3109/08820538.2013.810280. Epub 2013 Aug 23.
10
[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].[在细胞学和DNA图像细胞计量学控制下,用丝裂霉素C滴眼液治疗9例结膜原位鳞状上皮癌(CIN)病变]
Klin Monbl Augenheilkd. 2001 Jun;218(6):429-34. doi: 10.1055/s-2001-16257.

引用本文的文献

1
Management and outcomes of ocular surface squamous neoplasia at a tertiary hospital, South Africa.南非一家三级医院眼表鳞状上皮肿瘤的管理与治疗结果
Eye (Lond). 2025 Oct;39(14):2713-2719. doi: 10.1038/s41433-025-03926-8. Epub 2025 Jul 25.
2
Spontaneously resolved invasive conjunctival squamous cell carcinoma with anterior chamber invasion in low-grade lymphoma patient.低级别淋巴瘤患者中自发消退的伴有前房侵犯的浸润性结膜鳞状细胞癌
Am J Ophthalmol Case Rep. 2025 May 3;38:102348. doi: 10.1016/j.ajoc.2025.102348. eCollection 2025 Jun.
3
Iatrogenic Ocular Surface Complications After Surgery for Ocular and Adnexal Tumors.
眼及附属器肿瘤手术后的医源性眼表并发症
Cancers (Basel). 2025 Apr 22;17(9):1384. doi: 10.3390/cancers17091384.
4
Update in the Diagnosis and Management of Ocular Surface Squamous Neoplasia (OSSN).眼表鳞状上皮肿瘤(OSSN)诊断与管理的最新进展
J Clin Med. 2025 Mar 3;14(5):1699. doi: 10.3390/jcm14051699.
5
Oncological principles in the management of ocular surface squamous neoplasia - A Review.眼表鳞状上皮肿瘤管理中的肿瘤学原则——综述
Indian J Ophthalmol. 2025 Feb 1;73(2):173-190. doi: 10.4103/IJO.IJO_2340_24. Epub 2025 Jan 24.
6
New combined treatments, surgery and high-dose-rate interventional radiotherapy (brachytherapy), in advanced ocular surface and eyelid cancers.新型联合治疗、手术及高剂量率介入放射治疗(近距离放射治疗)用于晚期眼表及眼睑癌。
Transl Oncol. 2025 Jan;51:102160. doi: 10.1016/j.tranon.2024.102160. Epub 2024 Nov 5.
7
Excision combined with ocular surface reconstruction followed by topical chemotherapy for ocular surface squamous neoplasia.切除联合眼表重建联合局部化疗治疗眼表鳞状上皮肿瘤。
Jpn J Ophthalmol. 2024 Nov;68(6):731-740. doi: 10.1007/s10384-024-01111-0. Epub 2024 Oct 2.
8
Cytomorphological Spectrum of Ocular Surface Squamous Neoplasia in Elderly Age Group and Its Clinicopathological Correlation.老年人群眼表鳞状上皮肿瘤的细胞形态学谱及其临床病理相关性
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2624-S2627. doi: 10.4103/jpbs.jpbs_410_24. Epub 2024 Jul 1.
9
Novel automated non-invasive detection of ocular surface squamous neoplasia using artificial intelligence.利用人工智能对眼表鳞状细胞癌进行新型自动化无创检测。
World J Methodol. 2024 Jun 20;14(2):92267. doi: 10.5662/wjm.v14.i2.92267.
10
Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.局部 5-氟尿嘧啶治疗眼表鳞状上皮肿瘤的疗效:101 例眼分析。
Int Ophthalmol. 2024 Jun 22;44(1):251. doi: 10.1007/s10792-024-03182-x.